Compare Illumina, Inc. (ILMN) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Star Bulk Carriers Corp — how do they compare? Illumina, Inc. trades at $192.36 (market cap $27.94B), while Star Bulk Carriers Corp trades at $26.59 (market cap $2.91B). The key difference: Illumina, Inc. is far larger — about 9.6× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | SBLK | |
|---|---|---|
Market Cap | $27.94B | $2.91B |
Sector | Health | Industrials |
52-Week High | $194.33 | $28.21 |
52-Week Low | $91.00 | $16.79 |
Enterprise Value | $29.33B | $3.61B |
Dividend Yield | — | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $192.53, up 3.15% today, with bullish technical signals and strong fundamental recovery. The stock shows robust profitability with a 19.42% net margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and new executive appointments, reinforcing growth prospects in genomics.
Outlook remains positive driven by sequencing demand and cost control, but risks include competitive pressure from Roche's new sequencer and China market weakness. Analyst consensus is Buy with a $178 target, though the current price exceeds this, suggesting cautious optimism amid execution risks.
Star Bulk Carriers (SBLK) trades at $26.09, up 4.78% in the last session, with a neutral technical signal and bullish moving averages. The company reported strong earnings beats in Q4 2025 and Q1 2026, with Q2 2026 EPS expected at $0.96. Financials show improving profitability, with a net income margin of 13.01% in 2026, and a dividend of $0.50 paid in June 2026. Analyst consensus is bullish, with 14 buys out of 24 ratings.
SBLK's outlook is supported by robust free cash flow and a healthier balance sheet, but risks include spot rate volatility and broader market pressures. The stock offers potential for high dividend yields and earnings growth, though investor caution is warranted amid sector cyclicality and economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
